This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yajko, D M Articles by Hadley, W K Search for Related Content PubMed PubMed Citation Articles by Yajko, D M Articles by Hadley, W K

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 January; 31(1): 117-120

Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.

D M Yajko, P S Nassos and W K Hadley

ABSTRACT

Patients with the acquired immune deficiency syndrome (AIDS) with disseminated Mycobacterium avium infection have responded poorly to treatment with rifabutine (Ansamycin) and clofazimine, in spite of the good in vitro response of M. avium to these antimicrobial agents. We compared the ability of these and other antimicrobial agents to kill versus the ability to inhibit the growth of strains of the M. avium complex isolated from patients with AIDS. Killing curve experiments showed that the concentrations of rifabutine and clofazimine needed to kill two log units of M. avium are at least 32 times greater than the concentrations needed to inhibit growth. Little or no killing occurred at concentrations of these antimicrobial agents that are achievable in serum. In contrast, five of seven strains tested were killed by ciprofloxacin at concentrations that can be achieved in serum. Ciprofloxacin should be studied further for possible use in the treatment of M. avium infections.

---

Antimicrob Agents Chemother. 1987 January; 31(1): 117-120

This article has been cited by other articles:

• Wang, F., Langley, R., Gulten, G., Dover, L. G., Besra, G. S., Jacobs, W. R. Jr., Sacchettini, J. C. (2007). Mechanism of thioamide drug action against tuberculosis and leprosy. JEM 204: 73-78 [Abstract] [Full Text]  
• Maisetta, G., Batoni, G., Pardini, M., Boschi, A., Bottai, D., Esin, S., Campa, M., Senesi, S. (2001). Use of a Recombinant Strain of Mycobacterium avium Expressing {beta}-Galactosidase To Evaluate the Activities of Antimycobacterial Agents inside Macrophages. Antimicrob. Agents Chemother. 45: 356-358 [Abstract] [Full Text]  
• Packer, S. J., Cesario, T., Williams, J. H. Jr. (1988). Mycobacterium avium Complex Infection Presenting as Endobronchial Lesions in Immunosuppressed Patients. ANN INTERN MED 109: 389-393 [Abstract]